Prevalence of Intracranial Hemorrhage after Blunt Head Trauma in Patients on Pre-injury Dabigatran

Introduction: Dabigatran etexilate was the first direct-acting oral anticoagulant approved in the United States. The prevalence of intracranial hemorrhage after blunt head trauma in patients on dabigatran is currently unknown, complicating adequate ability to accurately compare the risks and benefit...

Full description

Bibliographic Details
Main Authors: James A. Chenoweth, M. Austin Johnson, Laura Shook, Mark E. Sutter, Daniel K. Nishijima, James F. Holmes
Format: Article
Language:English
Published: eScholarship Publishing, University of California 2017-07-01
Series:Western Journal of Emergency Medicine
Online Access:https://escholarship.org/uc/item/6dw824z4
_version_ 1811253581861355520
author James A. Chenoweth
M. Austin Johnson
Laura Shook
Mark E. Sutter
Daniel K. Nishijima
James F. Holmes
author_facet James A. Chenoweth
M. Austin Johnson
Laura Shook
Mark E. Sutter
Daniel K. Nishijima
James F. Holmes
author_sort James A. Chenoweth
collection DOAJ
description Introduction: Dabigatran etexilate was the first direct-acting oral anticoagulant approved in the United States. The prevalence of intracranial hemorrhage after blunt head trauma in patients on dabigatran is currently unknown, complicating adequate ability to accurately compare the risks and benefits of dabigatran to alternative anticoagulants. We aimed to determine the prevalence of intracranial hemorrhage for patients on dabigatran presenting to a Level I trauma center. Methods: This is a retrospective observational study of adult patients on dabigatran who presented to a Level I trauma center and received cranial computed tomography (CT) following blunt head trauma. Patients who met inclusion criteria underwent manual chart abstraction. Our primary outcome was intracranial hemorrhage on initial cranial CT. Results: We included a total of 33 eligible patient visits for analysis. Mean age was 74.8 years (SD 11.2, range 55–91). The most common cause of injury was ground-level fall (n = 22, 66.7%). One patient (3.0%, 95% confidence interval [CI] 0.[1–15.8%]) had intracranial hemorrhage on cranial CT. No patients (0%, 95% CI [0–8.7%]) required neurosurgical intervention. One in-hospital death occurred from infection. Conclusion: To our knowledge, this is the first study to evaluate the prevalence of intracranial hemorrhage after blunt head trauma for patients on dabigatran presenting to the emergency department, including those not admitted. The intracranial hemorrhage prevalence in our study is similar to previous reports for patients on warfarin. Further studies are needed to determine if the prevalence of intracranial hemorrhage seen in our patient population is true for a larger patient population in more diverse clinical settings.
first_indexed 2024-04-12T16:53:10Z
format Article
id doaj.art-d68ca782adb546e0bf026a707a5ded74
institution Directory Open Access Journal
issn 1936-9018
language English
last_indexed 2024-04-12T16:53:10Z
publishDate 2017-07-01
publisher eScholarship Publishing, University of California
record_format Article
series Western Journal of Emergency Medicine
spelling doaj.art-d68ca782adb546e0bf026a707a5ded742022-12-22T03:24:19ZengeScholarship Publishing, University of CaliforniaWestern Journal of Emergency Medicine1936-90182017-07-0118510.5811/westjem.2017.5.33092wjem-18-794Prevalence of Intracranial Hemorrhage after Blunt Head Trauma in Patients on Pre-injury DabigatranJames A. Chenoweth0M. Austin Johnson1Laura Shook2Mark E. Sutter3Daniel K. Nishijima4James F. Holmes5University of California Davis, School of Medicine, Department of Emergency Medicine, Davis, CaliforniaUniversity of California Davis, School of Medicine, Department of Emergency Medicine, Davis, CaliforniaUniversity of California Davis, School of Medicine, Davis, CaliforniaUniversity of California Davis, School of Medicine, Department of Emergency Medicine, Davis, CaliforniaUniversity of California Davis, School of Medicine, Department of Emergency Medicine, Davis, CaliforniaUniversity of California Davis, School of Medicine, Department of Emergency Medicine, Davis, CaliforniaIntroduction: Dabigatran etexilate was the first direct-acting oral anticoagulant approved in the United States. The prevalence of intracranial hemorrhage after blunt head trauma in patients on dabigatran is currently unknown, complicating adequate ability to accurately compare the risks and benefits of dabigatran to alternative anticoagulants. We aimed to determine the prevalence of intracranial hemorrhage for patients on dabigatran presenting to a Level I trauma center. Methods: This is a retrospective observational study of adult patients on dabigatran who presented to a Level I trauma center and received cranial computed tomography (CT) following blunt head trauma. Patients who met inclusion criteria underwent manual chart abstraction. Our primary outcome was intracranial hemorrhage on initial cranial CT. Results: We included a total of 33 eligible patient visits for analysis. Mean age was 74.8 years (SD 11.2, range 55–91). The most common cause of injury was ground-level fall (n = 22, 66.7%). One patient (3.0%, 95% confidence interval [CI] 0.[1–15.8%]) had intracranial hemorrhage on cranial CT. No patients (0%, 95% CI [0–8.7%]) required neurosurgical intervention. One in-hospital death occurred from infection. Conclusion: To our knowledge, this is the first study to evaluate the prevalence of intracranial hemorrhage after blunt head trauma for patients on dabigatran presenting to the emergency department, including those not admitted. The intracranial hemorrhage prevalence in our study is similar to previous reports for patients on warfarin. Further studies are needed to determine if the prevalence of intracranial hemorrhage seen in our patient population is true for a larger patient population in more diverse clinical settings.https://escholarship.org/uc/item/6dw824z4
spellingShingle James A. Chenoweth
M. Austin Johnson
Laura Shook
Mark E. Sutter
Daniel K. Nishijima
James F. Holmes
Prevalence of Intracranial Hemorrhage after Blunt Head Trauma in Patients on Pre-injury Dabigatran
Western Journal of Emergency Medicine
title Prevalence of Intracranial Hemorrhage after Blunt Head Trauma in Patients on Pre-injury Dabigatran
title_full Prevalence of Intracranial Hemorrhage after Blunt Head Trauma in Patients on Pre-injury Dabigatran
title_fullStr Prevalence of Intracranial Hemorrhage after Blunt Head Trauma in Patients on Pre-injury Dabigatran
title_full_unstemmed Prevalence of Intracranial Hemorrhage after Blunt Head Trauma in Patients on Pre-injury Dabigatran
title_short Prevalence of Intracranial Hemorrhage after Blunt Head Trauma in Patients on Pre-injury Dabigatran
title_sort prevalence of intracranial hemorrhage after blunt head trauma in patients on pre injury dabigatran
url https://escholarship.org/uc/item/6dw824z4
work_keys_str_mv AT jamesachenoweth prevalenceofintracranialhemorrhageafterbluntheadtraumainpatientsonpreinjurydabigatran
AT maustinjohnson prevalenceofintracranialhemorrhageafterbluntheadtraumainpatientsonpreinjurydabigatran
AT laurashook prevalenceofintracranialhemorrhageafterbluntheadtraumainpatientsonpreinjurydabigatran
AT markesutter prevalenceofintracranialhemorrhageafterbluntheadtraumainpatientsonpreinjurydabigatran
AT danielknishijima prevalenceofintracranialhemorrhageafterbluntheadtraumainpatientsonpreinjurydabigatran
AT jamesfholmes prevalenceofintracranialhemorrhageafterbluntheadtraumainpatientsonpreinjurydabigatran